Navigation Links
Beating superbugs with a high-tech cleanser
Date:12/9/2011

According to the World Health Organization, antibiotic-resistant bacteria are one of the top three threats to human health. Patients in hospitals are especially at risk, with almost 100,000 deaths due to infection every year in the U.S. alone.

Now Dr. Udi Qimron of the Department of Clinical Microbiology and Immunology at Tel Aviv University's Sackler Faculty of Medicine has developed an efficient and cost-effective liquid solution that can help fight antibiotic-resistant bacteria and keep more patients safe from life-threatening infections. The solution is based on specially designed bacteriophages viruses that infect bacteria that can alter the genetic make-up of antibiotic-resistant bacteria. "We have genetically engineered the bacteriophages so that once they infect the bacteria, they transfer a dominant gene that confers renewed sensitivity to certain antibiotics," explains Dr. Qimron.

The solution, recently detailed in the journal Applied and Environmental Microbiology, could be added to common antibacterial cleansers used on hospital surfaces, turning resistant bacteria into sensitive bacteria. It's easy to prepare, easy to apply, and non-toxic, Dr. Qimron notes. He estimates that one liter of the growth medium the liquid in which the bacteriophages are grown will cost just a few dollars.

The research was done in collaboration with Ph.D. student Nir Friedman, lab technician Shahar Mor, and Dr. Rotem Edgar of the Ichilov Medical Center.

Changing bacteria's genetics

Certain antibiotics are designed to target and bind to a part of the bacteria cell called a ribosome the protein factory of the cell. But after continual and frequent exposure to antibiotics, the bacteria "learn" to change components in the ribosome itself so that the antibiotics are unable to bind.

Dr. Qimron and his colleagues set out to determine whether they could make resistant bacteria sensitive to antibiotics again by re-introducing a component of the ribosome, a gene called rpsL, which restores bacteria's sensitivity to antibiotics. "Our novel approach relies on an effective delivery process and selection procedure, put on the same platform for the first time," says Dr. Qimron. With this system, the sensitive bacteria takes over the ecological niche once occupied by the resistant bacteria. And if a patient does happen to become infected by lingering bacteria anyway, traditional antibiotics can again be used as an effective treatment.

Two steps to disarming bacteria

Added to cleansers, Tellurite represents the second step in a two-part process. A Tellurite compound, which is toxic to bacteria, would also be spread on all surfaces to wipe out the bacteria that had not been rendered sensitive, and thus the entire population of the surface bacteria would be sensitized. The combination is designed to first disarm, and then kill dangerous bacteria.

Next, the solution will be tested in pre-clinical animal trials to ensure its safety before being made available for wider use at hospitals. Once its safety is guaranteed, the solution will come in a bottle, says Dr. Qimron, and easily added to a bucket or spray.


'/>"/>
Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert

Related medicine news :

1. Vaccination, Prevention Is Beating Back Hepatitis
2. Professional Web Design Agency Discovers Winning Web Development Formula for Beating the Recession.
3. Beating doctor burnout and protecting patients
4. Going live to the beating heart
5. Small particles show big promise in beating unpleasant odors
6. Overall Health May Be Key to Beating Breast Cancer
7. Tufts researcher elected 2010 AAAS Fellow for work in superbugs and heat-stable vaccines
8. Communication pathways within proteins may yield new drug targets to stop superbugs
9. Roads pave the way for the spread of superbugs
10. Left-handed iron corkscrews point the way to new weapon in battle against superbugs like MRSA
11. A high-tech handrest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Datta ... M.D. has joined the revolutionary endoscopic practice under Dr. Datta. Patel is a ... Pain Medicine. The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic ...
(Date:4/28/2017)... ... April 28, 2017 , ... People are starting to ... “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa wore his ... of Greater Boston, in a NALA North American Speaker Series (NASS) segment. ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... the Brooke Grove Foundation implement a Microsoft Dynamics GP solution that integrates to ... ERP expert that specializes in long-term care, Brooke Grove now has the capability ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
(Date:4/27/2017)... ... April 27, 2017 , ... The American Brain Foundation ... Leadership in Neurology Award (PLINA). The couple joins a prestigious list of past ... Walter Mondale, actor Michael J. Fox and former U.S. Attorney General Janet Reno. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and ... Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), ... Forecasts, 2014 - 2025" report to their offering. ... The Latin American pharmaceutical ... billion by 2025 Low drug registration cost in ...
(Date:4/19/2017)... The Mobile X-Ray product segment is the most ... the forecast period Mobile X-Ray segment is the ... X-Ray devices market, which is estimated to be valued at ... CAGR of 7% over the forecast period. Mobile X-Ray segment ... US$ 100 Mn in 2017 over 2016. The segment,s revenue ...
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
Breaking Medicine Technology: